1.gif (1892 bytes)

Immunization Dialogue

Indian Pediatrics 2000;37: 1279-1281.

Hib, Measles and Varicella Vaccine

 

  1. What is the ideal age for H. influenzae vaccination? Although the manufacturers recommend starting at 2 months of age, the information available in the journal is not very clear on this issue(1,2). Moreover, many practitioners and even some government hospitals are routinely giving the vaccine at 6 weeks of age (1 dose). Further, what is the ideal/recommended interval between the three doses of this vaccine during the primary schedule? I have noted many children who have received the first three doses at 1 month intervals along with the DPT vaccine. The manufacturers and various authorities in this field recommend a minimum interval of two months between the doses in the primary schedule. If the ideal age for Hib vaccine is 2 months, is it justifiable to delay DPT vaccination to 2 months of age?

  2. Can measles vaccine be given intra-muscularly? Many centers have been using this route for measles vaccine routinely.

  3. Varicella vaccine is known to cause a few (less than 50 usually) varicella like eruptions in around 4% of the vaccines. Does this also mean that the vaccine virus can get reactivated in later life and can cause Herpes zoster?

  4. What is the duration of protection with varicella vaccine and is there a need for booster?

Devendra Mishra,
163, Sahyog Apartments,
Mayur Vihar, Phase I,
Delhi 110 091, India.

 References
  1. John TJ. Hemophilus influenzae type b vaccine. Indian Pediatr 1998; 35: 71-72.

  2. John TJ. Transplacental transfer of H. influenzae type b antibody. Indian Pediatr 1998; 35: 919-920.

 Reply
  1. The protein conjugated Hib vaccines are immunogenic in young infants. Most studies have used the schedule of a dose each at 2, 4 and 6 months, according to the DPT schedule in the USA, and the immune responses have been very good. Therefore, it is quite reasonable to expect good antibody response even if the first dose is started at 6 weeks and the interval between doses is reduced to 4 weeks, to fit with the current schedule of DPT in India. Indeed there have been some studies confirming this. By 6 weeks, the maternal antibody level, low to begin with, would have declined markedly. Since the problem of invasive Hib disease begins by about 2-3 months and peaks around 6 to 12 months, it is very important to start the immunization schedule early than late. On the other hand, there is no longer any such hurry for DPT vaccines, particularly since pertussis, the main target for early start of DPT, is no longer rampant as it used to be in the pre-EPI days.

  2. Measles, MMR and Varicella vaccines are recommended to be given subcutaneously. We had conducted some studies, first in monkeys and later in children, giving measles vaccine intramuscularly, either by itself or along with DPT or DPT-Polio vaccines and the antibody responses to the measles virus have been as good as when it was given subcutaneously(1,2). So, the intramuscular route is acceptable, but the recommended route continues to be subcutaneous.

  3. Varicella vaccine does not usually cause any rash, but occasionally it can cause a maculopapular or even vesicular rash, but with very few vesicles. It appears that abundant skin vesicles are the source of seeding the virus into the posterior nerve root ganglia, where it may remain for many years to decades, and then spread peripherally along one nerve and cause unidermatomal herpes zoster. Since varicella vaccine virus is attenuated and also not usually associated with many vesicles, the likelihood of later herpes zoster is also very low after vaccination. In immunocompromised children herpes zoster has occurred, with the recovery of the vaccine virus from the vesicles, but in general, in normal children, varicella vaccine protects against varicella and herpes zoster.

  4. In Japan, varicella vaccine had been in use for over 20 years and the protective efficacy continues to be of the order of about 95%.

 References
  1. John TJ, Selvakumar R. Mixing measles vaccine with DPT and DPTP. Lancet 1985; p 1154.

  2. John TJ, Selvakumar R, Simoes EAF, Balraj V. Antibody response to measles vaccine given mixed with DPTP. Amer J Dis Child 1987; 141: 14-16.

T. Jacob John,
Emeritus Medical Scientist (ICMR),
439, Civil Supplies Godown Lane,
Kamalakshipuram,
Vellore TN 632 002,
India.

E-mail:
[email protected]

Home

Past Issue

About IP

About IAP

Feedback

Links

 Author Info.

  Subscription